Predicting End-Stage Renal Disease After Liver Transplant

被引:65
|
作者
Israni, A. K. [1 ,2 ,3 ]
Xiong, H. [2 ]
Liu, J. [2 ]
Salkowski, N. [2 ]
Trotter, J. F. [4 ]
Snyder, J. J. [2 ,3 ]
Kasiske, B. L. [1 ,2 ]
机构
[1] Univ Minnesota, Dept Med, Hennepin Cty Med Ctr, Minneapolis, MN 55455 USA
[2] Minneapolis Med Res Fdn Inc, Chron Dis Res Grp, Minneapolis, MN USA
[3] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA
[4] Baylor Univ, Med Ctr, Dallas, TX USA
关键词
End-stage renal disease; liver transplantation; registry analysis; risk prediction; CHRONIC KIDNEY-DISEASE; FAILURE; RECIPIENTS; IMPACT; ORGAN; MODEL; RISK; ALLOCATION; SELECTION;
D O I
10.1111/ajt.12257
中图分类号
R61 [外科手术学];
学科分类号
摘要
Few equations have been developed to predict end-stage renal disease (ESRD) after deceased donor liver transplant. This retrospective observational cohort study analyzed all adult deceased donor liver transplant recipients in the Scientific Registry of Transplant Recipients (SRTR) database, 1995-2010. The prediction equation for ESRD was developed using candidate predictor variables available in SRTR after implementation of the allocation policy based on the model for end-stage liver disease. ESRD was defined as initiation of maintenance dialysis therapy, kidney transplant or registration on the kidney transplant waiting list. We used Cox proportional hazard models to develop separate equations for assessing risk of ESRD by 6 months posttransplant and between 6 months and 5 years posttransplant. Variables in the 6-month equation included recipient age, history of diabetes, history of dialysis before liver transplant, history of malignancy, body mass index, serum creatinine and liver donor risk index. Variables in the 6-month to 5-year equation included recipient race, history of diabetes, hepatitis C status, serum albumin, serum bilirubin and serum creatinine. The prediction equations have good calibration and discrimination (C statistics 0.74-0.78). We have produced risk prediction equations that can be used to aid in understanding the risk of ESRD after liver transplant.
引用
收藏
页码:1782 / 1792
页数:11
相关论文
共 50 条
  • [1] Calciphylaxis in end-stage liver and renal disease patients before and after transplant
    Couri, Thomas
    Stier, Matthew
    Mikolajczyk, Adam
    Aronsohn, Andrew
    [J]. CLINICAL TRANSPLANTATION, 2018, 32 (06)
  • [2] Post-liver transplant acute renal failure: factors predicting development of end-stage renal disease
    Paramesh, AS
    Roayaie, S
    Doan, Y
    Schwartz, ME
    Emre, S
    Fishbein, T
    Florman, S
    Gondolesi, GE
    Krieger, N
    Ames, S
    Bromberg, JS
    Akalin, E
    [J]. CLINICAL TRANSPLANTATION, 2004, 18 (01) : 94 - 99
  • [3] Renal Dysfunction in End-Stage Liver Disease and Post-Liver Transplant
    Sampaio, Marcelo S.
    Martin, Paul
    Bunnapradist, Suphamai
    [J]. CLINICS IN LIVER DISEASE, 2014, 18 (03) : 543 - +
  • [4] End-stage renal disease after liver transplantation in patients with pre-transplant chronic kidney disease
    Bahirwani, Ranjeeta
    Forde, Kimberly A.
    Mu, Yifei
    Lin, Fred
    Reese, Peter
    Goldberg, David
    Abt, Peter
    Reddy, K. Rajender
    Levine, Matthew
    [J]. CLINICAL TRANSPLANTATION, 2014, 28 (02) : 205 - 210
  • [5] End-stage renal disease in liver transplants
    Lynn, M
    Abreo, K
    Zibari, G
    McDonald, J
    [J]. CLINICAL TRANSPLANTATION, 2001, 15 : 66 - 69
  • [6] Risk of End-Stage Renal Disease after Liver Transplant among Recipients with Sustained Pre-Transplant Renal Dysfunction.
    Goldberg, D.
    Ruebner, R.
    Bahirwani, R.
    Abt, P.
    Levine, M.
    Sawinski, D.
    Bloom, R.
    Reese, P.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 513 - 514
  • [7] Risk of End-Stage Renal Disease Among Liver Transplant Recipients With Pretransplant Renal Dysfunction
    Ruebner, R.
    Goldberg, D.
    Abt, P. L.
    Bahirwani, R.
    Levine, M.
    Sawinski, D.
    Bloom, R. D.
    Reese, P. P.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (11) : 2958 - 2965
  • [8] Predicting prognosis in patients with end-stage liver disease
    Ebell, Mark H.
    [J]. AMERICAN FAMILY PHYSICIAN, 2006, 74 (10) : 1762 - 1763
  • [9] End-Stage Renal Disease after Liver Transplantation in Patients with Pre-Transplant Chronic Kidney Disease.
    Bahirwani, R.
    Forde, K.
    Mu, Y.
    Lin, F.
    Reese, P.
    Abt, P.
    Reddy, R.
    Levine, M. H.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 509 - 510
  • [10] Renal Outcomes After Liver Transplantation in the Model for End-Stage Liver Disease Era
    Sharma, Pratima
    Welch, Kathy
    Eikstadt, Richard
    Marrero, Jorge A.
    Fontana, Robert J.
    Lok, Anna S.
    [J]. LIVER TRANSPLANTATION, 2009, 15 (09) : 1142 - 1148